Ticker
ETONCompany Name
ETON PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 101.68M | $ 25.38M | 24.96% |
3/31/2025 | $ 84.03M | $ 17.42M | 20.73% |
12/31/2024 | $ 76.12M | $ 14.94M | 19.62% |
9/30/2024 | $ 35.84M | $ 20.26M | 56.53% |
6/30/2024 | $ 31.82M | $ 17.69M | 55.6% |
3/31/2024 | $ 30.79M | $ 16.66M | 54.09% |
12/31/2023 | $ 31.74M | $ 21.39M | 67.39% |
9/30/2023 | $ 31.53M | $ 22.07M | 70.01% |
6/30/2023 | $ 30.93M | $ 21.57M | 69.72% |
3/31/2023 | $ 23.93M | $ 14.71M | 61.47% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ETON PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 7.33M ] / Assets [ $ 11.39M ]
(=) Cash to Assets [ 64.34% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |